Allena Pharmaceuticals
ALNA
ALNA was delisted on the 7th of September, 2022.
30 hedge funds and large institutions have $28.3M invested in Allena Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 7 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
20% more capital invested
Capital invested by funds: $23.6M → $28.3M (+$4.66M)
7% more funds holding
Funds holding: 28 → 30 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$3.33M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$917K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$783K |
| 4 |
Renaissance Technologies
New York
|
+$398K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$371K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.67M |
| 2 |
Morgan Stanley
New York
|
-$690K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$345K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$278K |
| 5 |
Millennium Management
New York
|
-$141K |
ALNA Hedge Fund Activity: Q1 2021 in Review
30 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q1 2021, worth a combined $28.3M — up 20% from $23.6M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ALNA positions and 7 closed out — a net gain of 2 holders — while 10 added to existing stakes and 6 trimmed.
The largest buyer was AIGH Capital Management, adding an estimated $3.33M. The largest seller was Point72 Asset Management, cutting an estimated $1.67M.
- 30 institutional investors held Allena Pharmaceuticals (ALNA) as of Q1 2021, up from 28 in Q4 2020.
- Funds reported $28.3M of Allena Pharmaceuticals stock for Q1 2021, up 20% quarter-over-quarter.
- 9 funds opened new Allena Pharmaceuticals positions in Q1 2021 and 7 closed out, a net change of +2 holders.
- The largest Allena Pharmaceuticals buyer in Q1 2021 was AIGH Capital Management, an estimated $3.33M added.
- The largest Allena Pharmaceuticals seller in Q1 2021 was Point72 Asset Management, an estimated $1.67M sold.
Based on aggregated 13F filings for Q1 2021.